Paper
23 October 2001 Laser therapy and macular degeneration
Ugo Menchini, Gianni Virgili, Fabrizio Giansanti, Giovanni Giacomelli, Stefania Cappelli
Author Affiliations +
Proceedings Volume 4606, Laser Florence 2000: A Window on the Laser Medicine World; (2001) https://doi.org/10.1117/12.446718
Event: Laser Florence 2000: A Window on the Laser Medicine World, 2000, Florence, Italy
Abstract
Among macular diseases, choroidal neovascularization (CNV) is one of the most common causes of visual loss, especially in the form associated with age-related macular degeneration and pathologic myopia. Research on these diseases has recently evaluated new treatment modalities that use laser light differently; among these, photodynamic therapy (PDT) has been introduced in the clinical practice, allowing us to expand the possibility of reducing visual loss in patients affected by CNV. With PDT, a photosensitizer (verteporfin, VisudyneTM) is injected intravenously, and it selectively binds to new vessels; low-power laser light exposure then activates the drug, leading to oxidative damage of the endothelium and new vessels thrombosis. Yet, other therapies, such as transpupillary termotherapy, or the use of photocoagulation to cause feeder-vessel occlusion, could proof effective, but they need further investigation.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Ugo Menchini, Gianni Virgili, Fabrizio Giansanti, Giovanni Giacomelli, and Stefania Cappelli "Laser therapy and macular degeneration", Proc. SPIE 4606, Laser Florence 2000: A Window on the Laser Medicine World, (23 October 2001); https://doi.org/10.1117/12.446718
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Visualization

Photodynamic therapy

Laser therapeutics

Eye

Laser coagulation

Angiography

Laser tissue interaction

Back to Top